Arrowhead spotlights key pancreatitis figures from Phase 3 lipid disease study to differentiate itself from Ionis

Arrowhead Pharmaceuticals has unveiled highly anticipated pancreatitis results from a late-phase trial of plozasiran for a rare lipid disorder, several months after reporting topline data …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Vertex’s big deal, biotech’s red numbers, & an industry history lesson

How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon? We cover all that and more this week on “The Readout

April 11, 2024

BMS details confirmatory trial win for KRAS inhibitor Krazati

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 2, 2024

Create the ultimate PC setup with these gaming computer desks – The Cannabist

Which gaming computer desk is best? Desks can be versatile additions to any home office or workspace, especially for gaming computer setups. The perfect gaming

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.